Research & Development



  “沒錯,左賢王蒙查就要死了。”   雲瑯從籃子里抓過一把浸泡過的小米丟進了水里,黏上魚餌之後重新把魚鉤放進水里。超碰caoprom超碰分类   “這有何難!”超碰人人最新上线视频   “咳咳咳……”又一陣劇烈的咳嗽聲從台階下面傳來,眾人聞聲看去,只見衛青咳嗽著被侍衛從台階下面抬上來,所到之處人人躲避,只有雲瑯,曹襄勇敢的迎了上去請安問好。   面對把玩著一枚金幣的鐘離遠,馬合羅不敢有任何的抵抗,一五一十的將自己被襲擊的經過說了一遍。超碰免费   即便是有別的部落這樣做了,他們也會成為別的小部落爭著侵犯的對象,在這種局面下,小部落只會消亡的更快。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo